ePrivacy and GPDR Cookie Consent by TermsFeed Generator

CLINDAMYCIN KABI

150MG/ML INJ SOL/INF CNC SOL 10X2ML

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 25.11.2021
Interruption of marketing 15.11.2021 0129836
Capacity/distribution reasons 22.11.2021
Resumption of marketing 09.11.2021
Interruption of marketing 19.10.2021 0129836
Capacity/distribution reasons 21.11.2021
Placing on the market 01.03.2009

All reports are available in the Overview.

Back to list